TCM Biotech International Future Growth
Future criteria checks 0/6
TCM Biotech International's EPS is expected to grow by 110.3% per annum.
Key information
n/a
Earnings growth rate
110.3%
EPS growth rate
| Biotechs earnings growth | 48.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?
Jan 31
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend
Jan 04We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt
Dec 07
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 1,082 | 34 | -10 | -5 | 1 |
| 6/30/2024 | 834 | 20 | 47 | 50 | N/A |
| 3/31/2024 | 902 | 19 | 2 | 6 | N/A |
| 12/31/2023 | 970 | 19 | -42 | -38 | N/A |
| 9/30/2023 | 932 | 16 | -13 | -7 | N/A |
| 6/30/2023 | 895 | 13 | 17 | 24 | N/A |
| 3/31/2023 | 849 | 16 | 32 | 38 | N/A |
| 12/31/2022 | 802 | 18 | 47 | 52 | N/A |
| 9/30/2022 | 761 | 13 | 40 | 45 | N/A |
| 6/30/2022 | 720 | 8 | 34 | 38 | N/A |
| 3/31/2022 | 711 | 5 | 21 | 26 | N/A |
| 12/31/2021 | 702 | 2 | 8 | 15 | N/A |
| 9/30/2021 | 694 | -2 | -23 | -10 | N/A |
| 6/30/2021 | 686 | -5 | -53 | -34 | N/A |
| 3/31/2021 | 712 | 10 | 0 | 20 | N/A |
| 12/31/2020 | 737 | 26 | 53 | 75 | N/A |
| 9/30/2020 | 719 | 34 | 72 | 88 | N/A |
| 6/30/2020 | 700 | 42 | 91 | 101 | N/A |
| 3/31/2020 | 635 | 24 | 32 | 40 | N/A |
| 12/31/2019 | 569 | 7 | -28 | -21 | N/A |
| 9/30/2019 | 564 | 10 | -28 | -6 | N/A |
| 6/30/2019 | 560 | 13 | -28 | 9 | N/A |
| 3/31/2019 | 550 | 19 | -23 | 18 | N/A |
| 12/31/2018 | 540 | 25 | -18 | 27 | N/A |
| 9/30/2018 | 534 | 22 | -31 | 12 | N/A |
| 6/30/2018 | 527 | 19 | -44 | -2 | N/A |
| 3/31/2018 | 534 | 19 | N/A | 30 | N/A |
| 12/31/2017 | 541 | 19 | N/A | 63 | N/A |
| 9/30/2017 | 535 | 22 | N/A | 32 | N/A |
| 6/30/2017 | 529 | 25 | N/A | 2 | N/A |
| 3/31/2017 | 518 | 29 | N/A | -35 | N/A |
| 12/31/2016 | 506 | 33 | N/A | -71 | N/A |
| 9/30/2016 | 494 | 32 | N/A | -39 | N/A |
| 6/30/2016 | 483 | 31 | N/A | -7 | N/A |
| 3/31/2016 | 476 | 26 | N/A | 2 | N/A |
| 12/31/2015 | 470 | 21 | N/A | 12 | N/A |
| 9/30/2015 | 430 | 25 | N/A | N/A | N/A |
| 6/30/2015 | 390 | 29 | N/A | 52 | N/A |
| 3/31/2015 | 352 | 29 | N/A | 51 | N/A |
| 12/31/2014 | 314 | 29 | N/A | 50 | N/A |
| 9/30/2014 | 323 | 29 | N/A | N/A | N/A |
| 6/30/2014 | 333 | 29 | N/A | 17 | N/A |
| 3/31/2014 | 324 | 22 | N/A | 15 | N/A |
| 12/31/2013 | 316 | 16 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4169's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 4169's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4169's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4169's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4169's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4169's Return on Equity is forecast to be high in 3 years time